Annual Accounts Payable
$945.90 K
-$2.73 M-74.29%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual accounts payable is $945.90 thousand, with the most recent change of -$2.73 million (-74.29%) on December 31, 2023.
- During the last 3 years, SABS annual accounts payable has fallen by -$6.44 million (-87.19%).
- SABS annual accounts payable is now -87.19% below its all-time high of $7.38 million, reached on December 31, 2020.
Performance
SABS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.30 M
+$125.70 K+10.73%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly accounts payable is $1.30 million, with the most recent change of +$125.70 thousand (+10.73%) on September 30, 2024.
- Over the past year, SABS quarterly accounts payable has increased by +$213.80 thousand (+19.74%).
- SABS quarterly accounts payable is now -82.43% below its all-time high of $7.38 million, reached on December 31, 2020.
Performance
SABS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SABS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.3% | +19.7% |
| 3 y3 years | -87.2% | -76.3% |
| 5 y5 years | -56.4% | -76.3% |
SABS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.8% | at low | -76.3% | +37.1% |
| 5 y | 5-year | -87.2% | at low | -82.4% | +37.1% |
| alltime | all time | -87.2% | at low | -82.4% | +37.1% |
SAB Biotherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.30 M(+10.7%) |
| Jun 2024 | - | $1.17 M(-5.5%) |
| Mar 2024 | - | $1.24 M(+31.1%) |
| Dec 2023 | $945.90 K(-74.3%) | $945.90 K(-12.7%) |
| Sep 2023 | - | $1.08 M(-22.8%) |
| Jun 2023 | - | $1.40 M(-2.9%) |
| Mar 2023 | - | $1.45 M(-60.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $3.68 M(-17.5%) | $3.68 M(-32.9%) |
| Sep 2022 | - | $5.48 M(+10.9%) |
| Jun 2022 | - | $4.94 M(-0.8%) |
| Mar 2022 | - | $4.98 M(+11.7%) |
| Dec 2021 | $4.46 M(-39.6%) | $4.46 M(-18.9%) |
| Jun 2021 | - | $5.50 M(-25.5%) |
| Dec 2020 | $7.38 M(+240.1%) | $7.38 M |
| Dec 2019 | $2.17 M | - |
FAQ
- What is SAB Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual accounts payable year-on-year change?
- What is SAB Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly accounts payable year-on-year change?
What is SAB Biotherapeutics annual accounts payable?
The current annual accounts payable of SABS is $945.90 K
What is the all time high annual accounts payable for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual accounts payable is $7.38 M
What is SAB Biotherapeutics annual accounts payable year-on-year change?
Over the past year, SABS annual accounts payable has changed by -$2.73 M (-74.29%)
What is SAB Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of SABS is $1.30 M
What is the all time high quarterly accounts payable for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly accounts payable is $7.38 M
What is SAB Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, SABS quarterly accounts payable has changed by +$213.80 K (+19.74%)